http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-970010762-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate | 1995-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-970010762-A |
| titleOfInvention | Novel quinoline carboxylic acid derivatives having 7- (4-aminomethyl-3-fluoroalkyloxime) pyrrolidine substituents and methods for their preparation |
| abstract | The present invention is a quinolone compound exhibiting excellent antimicrobial activity, in particular, a compound having a 4-aminomethyl-3-fluoroalkyloximepyrrolidine substituent at the 7-position of the quinolone mother nucleus, which has excellent antibacterial activity and broad antibacterial spectrum. But also a novel quinoline (naphthyridine) carboxylic acid derivative represented by the following general formula (I), which has superior absorption and pharmacokinetic properties than conventional quinolone antibiotics, pharmaceutically acceptable non-toxic salts thereof, physiologically Hydrolyzable esters, solvates and isomers thereof.n n n n n n n n Wherein Q, R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined in the specification. |
| priorityDate | 1995-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.